Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines

Por ARAKAWA, YASUHIRO, OZAKI, KOJI, OKAWA, YUTAKA, YAMADA, HISASHI
Publicado em 2013

Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells

Por Hideshima, Teru, Ikeda, Hiroshi, Chauhan, Dharminder, Okawa, Yutaka, Raje, Noopur, Podar, Klaus, Mitsiades, Constantine, Munshi, Nikhil C., Richardson, Paul G., Carrasco, Ruben D., Anderson, Kenneth C.
Publicado em 2009

Biologic sequelae of IκB kinase (IKK) inhibition in multiple myeloma: therapeutic implications

Por Hideshima, Teru, Chauhan, Dharminder, Kiziltepe, Tanyel, Ikeda, Hiroshi, Okawa, Yutaka, Podar, Klaus, Raje, Noopur, Protopopov, Alexei, Munshi, Nikhil C., Richardson, Paul G., Carrasco, Ruben D., Anderson, Kenneth C.
Publicado em 2009

Retraction: Fatty acid synthase is a novel therapeutic target in multiple myeloma

Por Okawa, Yutaka, Hideshima, Teru, Ikeda, Hiroshi, Raje, Noopur, Vallet, Sonia, Kiziltepe, Tanyel, Yasui, Hiroshi, Enatsu, Sotaro, Pozzi, Samantha, Breitkreutz, Iris, Cirstea, Diana, Santo, Loredana, Richardson, Paul, Anderson, Kenneth C.
Publicado em 2008

SNX-2112, a selective Hsp90 inhibitor, potently inhibits tumor cell growth, angiogenesis, and osteoclastogenesis in multiple myeloma and other hematologic tumors by abrogating sign...

Por Okawa, Yutaka, Hideshima, Teru, Steed, Paul, Vallet, Sonia, Hall, Steven, Huang, Ken, Rice, John, Barabasz, Amy, Foley, Brianna, Ikeda, Hiroshi, Raje, Noopur, Kiziltepe, Tanyel, Yasui, Hiroshi, Enatsu, Sotaro, Anderson, Kenneth C.
Publicado em 2009

AT7519, A NOVEL SMALL MOLECULE MULTI-CYCLIN DEPENDENT KINASE INHIBITOR, INDUCES APOPTOSIS IN MULTIPLE MYELOMA VIA GSK-3β ACTIVATION AND RNA POLYMERASE II INHIBITION

Por Santo, Loredana, Vallet, Sonia, Hideshima, Teru, Cirstea, Diana, Ikeda, Hiroshi, Pozzi, Samantha, Patel, Kishan, Okawa, Yutaka, Gorgun, Gullu, Perrone, Giulia, Calabrese, Elisabetta, Yule, Murray, Squires, Matt, Ladetto, Marco, Boccadoro, Mario, Richardson, Paul G, Munshi, Nikhil C., Anderson, Kenneth C., Raje, Noopur
Publicado em 2010

MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts

Por Vallet, Sonia, Raje, Noopur, Ishitsuka, Kenji, Hideshima, Teru, Podar, Klaus, Chhetri, Shweta, Pozzi, Samantha, Breitkreutz, Iris, Kiziltepe, Tanyel, Yasui, Hiroshi, Ocio, Enrique M., Shiraishi, Norihiko, Jin, Janice, Okawa, Yutaka, Ikeda, Hiroshi, Mukherjee, Siddhartha, Vaghela, Nileshwari, Cirstea, Diana, Ladetto, Marco, Boccadoro, Mario, Anderson, Kenneth C.
Publicado em 2007

PI3K/p110δ is a novel therapeutic target in multiple myeloma

Por Ikeda, Hiroshi, Hideshima, Teru, Fulciniti, Mariateresa, Perrone, Giulia, Miura, Naoya, Yasui, Hiroshi, Okawa, Yutaka, Kiziltepe, Tanyel, Santo, Loredana, Vallet, Sonia, Cristea, Diana, Calabrese, Elisabetta, Gorgun, Gullu, Raje, Noopur S., Richardson, Paul, Munshi, Nikhil C., Lannutti, Brian J., Puri, Kamal D., Giese, Neill A., Anderson, Kenneth C.
Publicado em 2010

Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary

Por Takeuchi, Hideki, Saeki, Toshiaki, Aiba, Keisuke, Tamura, Kazuo, Aogi, Kenjiro, Eguchi, Kenji, Okita, Kenji, Kagami, Yoshikazu, Tanaka, Ryuhei, Nakagawa, Kazuhiko, Fujii, Hirofumi, Boku, Narikazu, Wada, Makoto, Akechi, Tatsuo, Udagawa, Yasuhiro, Okawa, Yutaka, Onozawa, Yusuke, Sasaki, Hidenori, Shima, Yasuo, Shimoyama, Naohito, Takeda, Masayuki, Nishidate, Toshihiko, Yamamoto, Akifumi, Ikeda, Tadashi, Hirata, Koichi
Publicado no Int J Clin Oncol (2015)